How China’s Chokehold on Drugs, Chips and More Threatens the U.S.
[ad_1] BEIJING—China has demonstrated it can weaponize its control over global supply chains by constricting the flow of critical rare-earth minerals. President Trump went…
[ad_1] BEIJING—China has demonstrated it can weaponize its control over global supply chains by constricting the flow of critical rare-earth minerals. President Trump went…
[ad_1] For years, the U.S. and China have been locked in a pattern on the deadly issue of fentanyl. The White House pressures Beijing…
[ad_1] In March, Sen. Steve Daines traveled to Beijing with a group of American chief executives in hopes of calming a tense trade relationship…
[ad_1] President Trump’s vow to intervene against drug smugglers in Colombia widened a U.S. counternarcotics campaign in Latin America that began with military strikes…
[ad_1] President Trump said the U.S. would stop aid payments to Colombia, for decades a close U.S. ally, because of the country’s drug production.…
[ad_1] Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors [ad_2] Source link
[ad_1] Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections &…
[ad_1] By Andrea Figueras Roche said that the European Commission approved Tecentriq SC, a cancer immunotherapy subcutaneous injection for multiple cancer types. The Swiss…
[ad_1] Shares of Medical Properties Trust plummeted after the real estate investment trust said it is ramping up efforts to recover uncollected rent and…
[ad_1] The Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy — it appears…
[ad_1] (Updated with Friday’s closing prices.) The 2023 rally for stocks in the U.S. accelerated as more investors bought the idea that the Federal…
[ad_1] Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P…
[ad_1] Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription.…
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for…
[ad_1] Dec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer…
[ad_1] SmileDirectClub Inc. said late Friday it was winding down operations, effective immediately, seeming to cast its millions of customers adrift — except when…
[ad_1] By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The…
[ad_1] BERLIN—Bayer Chief Executive Bill Anderson said the company would bounce back quickly from a recent spate of bad news, and warned that a…
[ad_1] Stock futures pointed higher Friday as Wall Street returned for a shortened trading session following the Thanksgiving holiday. Retailers will be in focus…
[ad_1] These Stocks Are Moving the Most Today: Plug Power, Trade Desk, Doximity, Unity Software, Illumina, Wynn, and More [ad_2] Source link